Skip to main content
. 2018 Dec 3;11:449. doi: 10.3389/fnmol.2018.00449

Figure 2.

Figure 2

Effect of endogenous DREAM levels on PS2 endoproteolysis and PS2 gene expression. (A) Quantified Western blots with anti-PS2 antibody of hippocampal (Hpp) and cortical (Cx) extracts from wild-type (WT), DREAM deficient knockout (KO) and transgenic mice overexpressing dominant active DREAM (daDREAM). (B) Quantitative PCR (qPCR) analysis of PS2 mRNA levels in the hippocampus and the cerebral cortex from the same three genotypes as in (A). Ordinary one-way ANOVA with Holm-Sidak’s multiple comparison test (n = 11, for each genotype) *P < 0.05, **P < 0.01, ***P < 0.001.